Personette Sarah 4

What Happened
Sarah Personette, a director of LifeStance Health Group, Inc. (LFST), received an award of 17,746 restricted stock units (RSUs) on July 2, 2026. The Form 4 reports the acquisition as an award (transaction code A) at $0.00 per unit (total reported value $0). RSUs are a form of compensation that convert into shares only if and when vesting conditions are met — this is not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-02; Form 4 filed: 2026-07-07 (filed several days after the transaction; appears late relative to the usual 2-business-day Form 4 deadline).
• Transaction type/code: Award/Grant (A).
• Amount: 17,746 RSUs reported at $0.00 per unit.
• Shares owned after the transaction: Not disclosed in the filing.
• Footnote: The grant “includes 17,746 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer’s common stock.”
• No sale, purchase, or option exercise reported in this filing.

Context
RSU grants are common director or employee compensation and reflect future potential ownership if vesting conditions are met; they do not necessarily signal immediate insider buying or selling. Taxes and any withholding are typically handled at vesting/delivery, and future Form 4s may report conversion of RSUs into shares or any subsequent sales. Investors tracking insider activity should watch for vesting events or later filings that show shares issued or sold.